Learn more

UNIV HACKENSACK MEDICAL CENTER

Overview
  • Total Patents
    55
  • GoodIP Patent Rank
    26,760
  • Filing trend
    ⇩ 84.0%
About

UNIV HACKENSACK MEDICAL CENTER has a total of 55 patent applications. It decreased the IP activity by 84.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are Healios Kk, VETERINAERMEDIZINISCHE UNIV WIEN and VETERINARMEDIZINISCHE UNIV WIEN.

Patent filings per year

Chart showing UNIV HACKENSACK MEDICAL CENTERs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhao Yong 21
#2 Zilberberg Jenny 9
#3 Korngold Robert 9
#4 Aslam Rummana 7
#5 Zhang Wenting 7
#6 Donato Michele 7
#7 Lee Woo 6
#8 Schwartz David 5
#9 Iyengar Sujatha 5
#10 Gu Yexin 4

Latest patents

Publication Filing date Title
WO2020163536A1 Ureteral stent and retrieval means
US2019231823A1 Rejuvenated aged hematopoietic stem cells and methods of use
EP3519560A1 Well plate-based perfusion culture model of endosteal-, extracellular matrix (ecm)- and endothelial- myeloma interactions and methods for testing personalized therapeutics for multiple myeloma
KR20190042079A Methods for treating immune disorder-related disorders by reducing autoreactivity in T cell compartments
CA3033539A1 Compositions and methods for reprogramming adult cells through the stemness of a platelet rich fraction of blood containing platelet-like cells in humans
EP3504320A1 Compositions and methods for programming adult cells with platelet rich fraction of blood containing platelet-like cells
US2018276341A1 Secure person identification and tokenized information sharing
AU2017217527A1 Compositions and methods for treating chronic wounds
US2016361300A1 Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
CA2972846A1 Ex vivo methods for minimizing risks and maximizing benefits of allogeneic blood and marrow transplantation
EP3186638A1 Serine proteases as biomarkers for ovarian cancer
AU2015226976A1 Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) as biomarkers for poor outcome Hodgkin lymphoma patients
AU2015204239A1 Method for treating skin cancer using radiation therapy